Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')<inf>2</inf> fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, phase 1 study

The Lancet Infectious Diseases

Saved in:

Bibliographic Details
Main Authors:	Bal, C�line, Herbreteau, C�cile H�l�ne, Buchy, Philippe, Rith, Sareth, Zaid, Masliza, Kristanto, William, Han, Velda, Reynaud, Charlotte, Granjard, Patrick, Lepine, Bertrand, Durand, Caroline, Tambyah, Paul Anantharajah
Other Authors:	MEDICINE
Format:	Article
Published:	Lancet Publishing Group 2016
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/123785
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-123785
record_format	dspace
spelling	sg-nus-scholar.10635-1237852023-10-31T21:55:55Z Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')<inf>2</inf> fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, phase 1 study Bal, C�line Herbreteau, C�cile H�l�ne Buchy, Philippe Rith, Sareth Zaid, Masliza Kristanto, William Han, Velda Reynaud, Charlotte Granjard, Patrick Lepine, Bertrand Durand, Caroline Tambyah, Paul Anantharajah MEDICINE The Lancet Infectious Diseases 15 3 285-292 2016-05-06T03:50:45Z 2016-05-06T03:50:45Z 2015 Article Bal, C�line, Herbreteau, C�cile H�l�ne, Buchy, Philippe, Rith, Sareth, Zaid, Masliza, Kristanto, William, Han, Velda, Reynaud, Charlotte, Granjard, Patrick, Lepine, Bertrand, Durand, Caroline, Tambyah, Paul Anantharajah (2015). Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')<inf>2</inf> fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, phase 1 study. The Lancet Infectious Diseases 15 (3) : 285-292. ScholarBank@NUS Repository. 14733099 http://scholarbank.nus.edu.sg/handle/10635/123785 000350268500026 Lancet Publishing Group
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	The Lancet Infectious Diseases
author2	MEDICINE
author_facet	MEDICINE Bal, C�line Herbreteau, C�cile H�l�ne Buchy, Philippe Rith, Sareth Zaid, Masliza Kristanto, William Han, Velda Reynaud, Charlotte Granjard, Patrick Lepine, Bertrand Durand, Caroline Tambyah, Paul Anantharajah
format	Article
author	Bal, C�line Herbreteau, C�cile H�l�ne Buchy, Philippe Rith, Sareth Zaid, Masliza Kristanto, William Han, Velda Reynaud, Charlotte Granjard, Patrick Lepine, Bertrand Durand, Caroline Tambyah, Paul Anantharajah
spellingShingle	Bal, C�line Herbreteau, C�cile H�l�ne Buchy, Philippe Rith, Sareth Zaid, Masliza Kristanto, William Han, Velda Reynaud, Charlotte Granjard, Patrick Lepine, Bertrand Durand, Caroline Tambyah, Paul Anantharajah Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')<inf>2</inf> fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, phase 1 study
author_sort	Bal, C�line
title	Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')<inf>2</inf> fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, phase 1 study
title_short	Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')<inf>2</inf> fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, phase 1 study
title_full	Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')<inf>2</inf> fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, phase 1 study
title_fullStr	Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')<inf>2</inf> fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, phase 1 study
title_full_unstemmed	Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')<inf>2</inf> fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, phase 1 study
title_sort	safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin f(ab')<inf>2</inf> fragments against avian influenza a (h5n1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, phase 1 study
publisher	Lancet Publishing Group
publishDate	2016
url	http://scholarbank.nus.edu.sg/handle/10635/123785
_version_	1781789818327400448

Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')<inf>2</inf> fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, phase 1 study

Similar Items